What is the address of M&M THERAPY?

The registered office of M&M THERAPY is located at Rue du Chêne(THN) 19, 6530 Thuin.

Is M&M THERAPY still active?

Yes. According to the CBE (31 October 2026) M&M THERAPY is active, legal situation “Normale toestand”, started on 12 July 2012.

Is M&M THERAPY registered on Peppol?

No, M&M THERAPY is currently not registered on the Peppol network.

What is the enterprise number of M&M THERAPY?

The enterprise number of M&M THERAPY is BE0847354782.

When was M&M THERAPY founded?

M&M THERAPY was founded on 12 July 2012.

Who are the directors of M&M THERAPY?

According to the 2025 annual accounts, the directors of M&M THERAPY are: Mike MOYSE.

Is M&M THERAPY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 July 2012; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did M&M THERAPY make in 2025?

M&M THERAPY posted a profit after taxes of € 6,223 in financial year 2025.

What is the revenue of M&M THERAPY?

As a small company, M&M THERAPY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 18,972.

M&M THERAPY (Private Limited) - Thuin - BE0847354782

Dossier M&M THERAPY, printed on 31 October 2026 from databakkes.be/en/0847354782/m-m-therapy. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

M&M THERAPY from Thuin, company number BE0847354782, closed financial year 2025 with a result of € 6,223 after tax. For that financial year M&M THERAPY recorded a gross margin of € 18,972 and equity of € 24,759. Compared with financial year 2024, the result moved from € 12,678 to € 6,223. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.

What it is worth Healthy

€ 24,759

▼ 19% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 6,223

▼ 51% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 29,717

▼ 7% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 12,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 2,074

▼ 10% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 21,082

▼ 11% vs 2024

€ 9,793 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 4

▼ 95% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 252

▼ 90% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 18,154 Gross margin 2022: € 18,154 First fiscal year in the series	€ 2,494 Gross margin 2023: € 2,494 ▼ 86% vs 2022 (€ 18,154) Unfavourable step	€ 27,660 Gross margin 2024: € 27,660 ▲ € 25,166 vs 2023 (€ 2,494) Favourable step	€ 18,972 Gross margin 2025: € 18,972 ▼ 31% vs 2024 (€ 27,660) Unfavourable step	▼ 31%
Profit after taxes	€ 11,115 Profit after taxes 2022: € 11,115 First fiscal year in the series	€ -6,064 Profit after taxes 2023: € -6,064 ▼ € 17,179 vs 2022 (€ 11,115) Unfavourable step	€ 12,678 Profit after taxes 2024: € 12,678 ▲ € 18,742 vs 2023 (€ -6,064) Favourable step	€ 6,223 Profit after taxes 2025: € 6,223 ▼ 51% vs 2024 (€ 12,678) Unfavourable step	▼ 51%
Equity	€ 49,922 Equity 2022: € 49,922 First fiscal year in the series	€ 24,858 Equity 2023: € 24,858 ▼ 50% vs 2022 (€ 49,922) Unfavourable step	€ 30,536 Equity 2024: € 30,536 ▲ 23% vs 2023 (€ 24,858) Favourable step	€ 24,759 Equity 2025: € 24,759 ▼ 19% vs 2024 (€ 30,536) Unfavourable step	▼ 19%
Total debts	€ 12,537 Total debts 2022: € 12,537 First fiscal year in the series	€ 46,010 Total debts 2023: € 46,010 ▲ 267% vs 2022 (€ 12,537) Unfavourable step	€ 33,271 Total debts 2024: € 33,271 ▼ 28% vs 2023 (€ 46,010) Favourable step	€ 33,351 Total debts 2025: € 33,351 Unchanged (€ 33,271) Unfavourable step
Cash	€ 31,349 Cash 2022: € 31,349 First fiscal year in the series	€ 23,889 Cash 2023: € 23,889 ▼ 24% vs 2022 (€ 31,349) Unfavourable step	€ 31,800 Cash 2024: € 31,800 ▲ 33% vs 2023 (€ 23,889) Favourable step	€ 29,717 Cash 2025: € 29,717 ▼ 7% vs 2024 (€ 31,800) Unfavourable step	▼ 7%
Retained profit	€ 31,322 Retained profit 2022: € 31,322 First fiscal year in the series	€ 6,258 Retained profit 2023: € 6,258 ▼ 80% vs 2022 (€ 31,322) Unfavourable step	€ 11,936 Retained profit 2024: € 11,936 ▲ 91% vs 2023 (€ 6,258) Favourable step	€ 6,159 Retained profit 2025: € 6,159 ▼ 48% vs 2024 (€ 11,936) Unfavourable step	▼ 48%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 19,000 Dividend 2023: € 19,000 Unchanged (€ 0) Unchanged	€ 7,000 Dividend 2024: € 7,000 ▼ 63% vs 2023 (€ 19,000) Unchanged	€ 12,000 Dividend 2025: € 12,000 ▲ 71% vs 2024 (€ 7,000) Unchanged	▲ 71%
Bank debt	€ 10,905 Bank debt 2022: € 10,905 First fiscal year in the series	€ 25,690 Bank debt 2023: € 25,690 ▲ 136% vs 2022 (€ 10,905) Unfavourable step	€ 23,634 Bank debt 2024: € 23,634 ▼ 8% vs 2023 (€ 25,690) Favourable step	€ 21,082 Bank debt 2025: € 21,082 ▼ 11% vs 2024 (€ 23,634) Favourable step	▼ 11%
Balance sheet total	€ 62,459 Balance sheet total 2022: € 62,459 First fiscal year in the series	€ 70,868 Balance sheet total 2023: € 70,868 ▲ 13% vs 2022 (€ 62,459) Unchanged	€ 63,807 Balance sheet total 2024: € 63,807 ▼ 10% vs 2023 (€ 70,868) Unchanged	€ 58,110 Balance sheet total 2025: € 58,110 ▼ 9% vs 2024 (€ 63,807) Unchanged	▼ 9%

Key figures of M&M THERAPY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to M&M THERAPY?

What happened at M&M THERAPY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 23, 2026 New annual accounts for financial year 2025: profit of € 6,223 (▼ 51% vs 2024). Source: NBB ↗
Aug 21, 2012 New establishment in Thuin. KBO
Jul 12, 2012 Start of the company according to the CBE. KBO

In short

From € 11,115 profit in 2022 to € 6,223 profit in 2025.

Paid € 7,955 in corporate taxes since 2022.

Best year ever: 2024, with € 12,678 profit.

Paid out € 38,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Mike MOYSE

M&M THERAPY

Behind M&M THERAPY is Mike MOYSE.

Directors

According to the 2025 annual accounts

Mike MOYSE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Chêne(THN) 19

6530 Thuin

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0847.354.782
VAT number: BE 0847.354.782
Registered office: Rue du Chêne(THN) 19, 6530 Thuin
Names & denominations: M&M THERAPY
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 12 July 2012
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗